A Message from the New Rho Chi President...
February 1, 2012 - Featured , Professional Advice / Opinions By: Yining Shao – Greetings fellow Rho Chi members and fellow pharmacy candidates! In thinking about my presidency, the following comes to mind: “Leadership and learning are indispensable to each other.” This quote, first stated by John F. Kennedy, remains true today. To be a good leader is not to simply dictate, but rather to… |
|
Adapting to the Changing Roles in Pharmacy...
February 1, 2012 - Featured , Professional Advice / Opinions By: Kate Croegaert, University of Iowa College of Pharmacy, Pharm.D. Candidate c/o 2013 – Kate Croegaert is a PharmD Candidate (Class of 2013) and the current President of the Rho Chi Delta Chapter at the University of Iowa College of Pharmacy. She believes in the importance of advancing the profession of pharmacy and promoting innovative practices… |
|
Brilinta® vs. Plavix® in Patients with Acute Coronary...
February 1, 2012 - Clinical , Featured By: Ronik Saha, Pharm.D. Candidate c/o 2013 – Clopidogrel (Plavix®) is a thienopyridine antiplatelet agent, which exerts its antiplatelet effects via in vivo conversion to an active thiol metabolite that irreversibly blocks the P2Y-12 component of platelet ADP receptors. This prevents activation of the GP2B/3A complex, thereby preventing platelet aggregation. Along with aspirin, clopidogrel reduces… |
|
Bydureon®: A Weekly Injection for Type 2 Diabetes Mell...
February 1, 2012 - Clinical , Featured , In the News / Politics By: Mohamed Dungersi – On January 27, the FDA approved Bydureon® (exenatide extended-release) for use in Type 2 Diabetes Mellitus (T2DM), as an adjunct to diet and exercise. Bydureon®, a product of Amylin Pharmaceuticals, is a modified formulation of the twice-daily injection, Byetta® (exenatide). It is the first once-a-week medication for T2DM in the market.… |
|
EPIC Spells Trouble for Many Seniors...
February 1, 2012 - In the News / Politics By: Ebey P. Soman – New York State’s Elderly Pharmaceutical Insurance Coverage Program (EPIC) is a secondary prescription insurance program for over 280,000 income-eligible seniors aged 65 and older. The program supplements members’ out-of-pocket Medicare Part D drug plan costs. To be eligible, the senior must be a state resident with an annual income of… |
|
Express Scripts and Medco Merger...
February 1, 2012 - In the News / Politics By: Mahdieh Danesh Yazdi – Express Scripts Inc., one of the nation’s top pharmacy benefit managers (PBMs), has announced a $29 billion deal to take over one of its top competitors, Medco Health Solutions Inc. Medco shareholders re-approved the merger on December 21. For finalization, it needs the approval of Express Scripts’ shareholders and the… |
|
Express, Be Involved, and Grow...
February 1, 2012 - Professional Advice / Opinions By: Dr. Gregory J. Hughes – Gregory J. Hughes, PharmD, BCPS, CGP is an Assistant Clinical Professor in the Clinical Pharmacy Practice department at St. John’s University College of Pharmacy and Allied Health Professions. He completed his pharmacy practice residency at the St. Louis VA Medical Center and the St. Louis College of Pharmacy with… |
|
Link Revealed: PPI Usage, Smoking and Bone Fractures...
February 1, 2012 - Clinical , In the News / Politics By: Ebey P. Soman – Proton pump inhibitors (PPIs) are medications commonly prescribed to treat heartburn, acid reflux disease, and ulcers. Almost a vast majority of patients in the United States seem to be taking a PPI, either as a prescription or from over-the-counter (OTC). Researchers recently discovered associations between the long-term use of PPIs… |
|
Medco & Express Scripts Merger...
February 1, 2012 - In the News / Politics By: Alisha Kumar, PharmD Candidate c/o 2012 – Express Scripts proposed a $29 billion acquisition of Medco Health back in July 2011, and Medco’s shareholders almost unanimously accepted the offer. According to Medco’s press release, the plan was approved by a margin of 99% to 1%, with approximately 72% of its shareholders voting. The two… |
|
My Residency, My Experience, A Foundation for My Career...
February 1, 2012 - Professional Advice / Opinions By: Sum Lam, PharmD, CGP, BCPS, FASCP – Sum Lam, Pharm.D., CGP, BCPS, FASCP is an Associate Clinical Professor in the Department of Clinical Pharmacy Practice at St. John’s University College of Pharmacy and Allied Health Professions. In conjunction with her full time appointment at St. John’s University, she is a clinical faculty at Geriatric… |
|
Pharmacists Are Healthcare Providers!...
February 1, 2012 - Featured , Professional Advice / Opinions By: Sandra Leal Pharm.D., CDE – Sandra Leal, PharmD, CDE is the Director of Clinical Pharmacy at El Rio Health Center in Tucson, Arizona. Dr. Leal is the first pharmacist in Arizona to receive prescriptive authority under collaborative practice. She is currently the Co-Chair of HRSA’s Patient Safety and Clinical Pharmacy Services Collaborative, a national… |
|
Pharmacy Practice Residency Training Programs...
February 1, 2012 - Professional Advice / Opinions By Dr. Tina Kanmaz – Dr. Kanmaz is the Assistant Dean for Experiential Pharmacy Education and Associate Clinical Professor at St. John’s University College of Pharmacy and Allied Health Professions. Pharmacy practice residency training is a one-year program that serves as a bridge for the recent Doctor of Pharmacy graduate (with little to no independent… |
|
Proton Pump Inhibitors and the Treatment of Osteoporosi...
February 1, 2012 - Clinical , Featured By: Neal Shah – Osteoporosis is a disease of the bone characterized by decreased bone mineral density (BMD), which reduces the ability of bone to provide adequate structural support. The main cause of this decreased BMD is inadequate calcium intake or absorption. The decreased BMD can cause diffuse lesions throughout the skeletal system and can… |
|
Puzzle: Word Search...
February 1, 2012 - Puzzles By: Marie Huang – H N N E O L P A A R I A P E E A A E P T E R I L A S E S N N I R I P S A R H C A N H R O A A H L I P L… |
|
Residency Experiences: Direct Impact on Professional De...
February 1, 2012 - Professional Advice / Opinions By Dr. Sharon See, PharmD, FCCP, BCPS – Sharon See, Pharm.D., FCCP, BCPS is an Associate Clinical Professor in the Clinical Pharmacy Practice Department at St. John’s University College of Pharmacy and Allied Health Professions. In conjunction with her full time appointment at St. John’s University, she is a clinical faculty member in the Beth… |
|
Should Plan B Have an Age Restriction?...
February 1, 2012 - Professional Advice / Opinions By: Marie Huang – Back in December, the FDA was overruled by the presidential administration to make Plan B (levonorgestrel 1.5 mg) an over-the-counter (OTC) medication.1 We became interested in the matter, and asked our fellow students if Plan B should be available to people of all ages directly off of drugstore / supermarket shelves… |
|
Student Pharmacist Star of the Month: Yining Shao...
February 1, 2012 - Professional Advice / Opinions By: Marie Huang – Each month, Rho Chi Post has the wonderful opportunity to sit down with an inspiring leader among the student pharmacists here at St. John’s University College of Pharmacy and Allied Health Professions – someone who is not afraid to stand apart from the crowd and can be the change he or… |
|
The Importance of Researching Residency Sites...
February 1, 2012 - Professional Advice / Opinions By: Dr. Regina Ginzburg – Regina Ginzburg is an Associate Clinical Professor of St. John’s University College of Pharmacy and Allied Health Professions. Her clinical site is at the Institute for Family Health (IFH) where she is an appointed faculty member for the Beth Israel Residency in Urban Family Health. She and Dr. See oversee… |
|
The Latest Novartis Recalls...
February 1, 2012 - In the News / Politics By: Aleena Chacko, Long Island University Pharm.D. Candidate c/o 2013 – Established in 1996, Novartis International AG is a multinational pharmaceutical company based in Switzerland. On January 8, 2012, Novartis issued a recall on some popular over the counter (OTC) medications in the United States (U.S.) over concerns about broken or incorrect tablets ending up… |